JBP Global USA

JBP Global USA is the American subsidiary of Japan Bio Products Co., Ltd., the world's leading manufacturer of placental extract-based pharmaceuticals and cosmetics. The company specializes in the development of high-quality biological products derived from human placenta, most notably the ethical drug Laennec used for liver regeneration and chronic liver disease. In the United States, JBP Global USA primarily focuses on the distribution of advanced medical devices, such as the ultra-thin JBP Nanoneedle, and aesthetic products like the Curacen line for skin rejuvenation. Their research emphasizes the therapeutic potential of growth factors, cytokines, and amino acids found in placental tissue to address aging and inflammatory conditions. The company operates under strict GMP standards to ensure the safety and viral inactivation of its biological extracts. JBP Global USA serves as a key bridge for bringing Japanese regenerative medicine innovations to the North American aesthetic and wellness markets.